Growth Metrics

Intelligent Bio Solutions (INBS) EBITDA Margin (2019 - 2025)

Intelligent Bio Solutions' quarterly EBITDA Margin came in at 334.03% in Q1 2025, up 4601.0% year-on-year from 7.11% in Q1 2024, and up 15.45% quarter-over-quarter from 395.06% in Q4 2024.

Intelligent Bio Solutions has reported EBITDA Margin for 7 years, with the latest figure at 334.03% in Q1 2025.

  • For the quarter ending Q1 2025, EBITDA Margin rose 4601.0% year-over-year to 334.03%; the trailing twelve-month figure through Mar 2025 stood at 333.88% (up 2275.0% YoY), and the FY2023 full-year result was 831.58%, down 29068.0% from the prior year.
  • EBITDA Margin for Q1 2025 stood at 334.03%, up from 395.06% in the prior quarter.
  • The five-year high for EBITDA Margin was 16.54% in Q4 2022, with the low at 9929.13% in Q1 2021.
  • Average EBITDA Margin over 5 years is 1153.12%, with a median of 380.04% recorded in 2024.
  • Year-over-year, EBITDA Margin sank 804890 bps in 2021 and jumped 923695 bps in 2022.
  • Tracing INBS's EBITDA Margin over 5 years: stood at 1941.97% in 2021, then jumped by 99 bps to 16.54% in 2022, then tumbled by 1404 bps to 248.83% in 2023, then tumbled by 59 bps to 395.06% in 2024, then grew by 15 bps to 334.03% in 2025.
  • The last three EBITDA Margin figures came in at 334.03% (Q1 2025), 395.06% (Q4 2024), and 284.13% (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 -334.03%
Dec 31, 2024 -395.06%
Sep 30, 2024 -284.13%
Mar 31, 2024 -380.04%
Dec 31, 2023 -248.83%
Sep 30, 2023 -306.90%
Jun 30, 2023 -588.31%
Mar 31, 2023 -1,405.01%
Dec 31, 2022 -16.54%
Sep 30, 2022 -388.40%
Jun 30, 2022 -180.72%
Mar 31, 2022 -692.18%
Dec 31, 2021 -1,941.97%
Jun 30, 2021 -205.49%
Mar 31, 2021 -9,929.13%
Dec 31, 2020 -688.99%
Sep 30, 2020 -2,026.23%
Jun 30, 2020 4,405.44%
Mar 31, 2020 -1,880.23%
Dec 31, 2019 -213,523.18%